[
  {
    "ts": "2025-12-23T05:16:10+00:00",
    "headline": "Jim Cramer Highlights Alphabet’s Diverse Portfolio",
    "summary": "Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer answered questions about. Starting the round of “Am I Diversified?”, a caller mentioned that their top five portfolio holdings are JPM, GOOGL, BA, PG, and AVGO. Cramer commented: “Let’s go to work in a year of practical investing, it’s upcoming…. Okay, so Broadcom, we know […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-highlights-alphabet-diverse-051610017.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ac731bad-0fd2-32bf-b761-c63d9463482d",
      "content": {
        "id": "ac731bad-0fd2-32bf-b761-c63d9463482d",
        "contentType": "STORY",
        "title": "Jim Cramer Highlights Alphabet’s Diverse Portfolio",
        "description": "",
        "summary": "Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer answered questions about. Starting the round of “Am I Diversified?”, a caller mentioned that their top five portfolio holdings are JPM, GOOGL, BA, PG, and AVGO. Cramer commented: “Let’s go to work in a year of practical investing, it’s upcoming…. Okay, so Broadcom, we know […]",
        "pubDate": "2025-12-23T05:16:10Z",
        "displayTime": "2025-12-23T05:16:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/af2bb6bdbc4f56cfaf197a2118a94cf1",
          "originalWidth": 1920,
          "originalHeight": 1440,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nKnWLQdPRocSASPR1jBwNw--~B/aD0xNDQwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/af2bb6bdbc4f56cfaf197a2118a94cf1.cf.webp",
              "width": 1920,
              "height": 1440,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ce5Jvbw3eVbn9NuhVM6ITg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/af2bb6bdbc4f56cfaf197a2118a94cf1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-highlights-alphabet-diverse-051610017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-highlights-alphabet-diverse-051610017.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "BA"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "AVGO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T05:05:56+00:00",
    "headline": "Why Analysts See St. James's Place Undervalued As Its Investment Story Evolves",
    "summary": "St. James's Place has seen its fair value estimate nudged higher to about £15.42 per share, as analysts grow more confident that the wealth manager can deliver on its earnings and capital generation plans. This modest uplift reflects a market narrative that is becoming more constructive, yet still mindful of regulatory and execution risks that could limit a more aggressive rerating. Stay tuned to see how investors can track these evolving price targets and the shifting story behind them over...",
    "url": "https://finance.yahoo.com/news/why-analysts-see-st-jamess-050556451.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "22cef689-6764-3f91-a5b6-17f65e4939d1",
      "content": {
        "id": "22cef689-6764-3f91-a5b6-17f65e4939d1",
        "contentType": "STORY",
        "title": "Why Analysts See St. James's Place Undervalued As Its Investment Story Evolves",
        "description": "",
        "summary": "St. James's Place has seen its fair value estimate nudged higher to about £15.42 per share, as analysts grow more confident that the wealth manager can deliver on its earnings and capital generation plans. This modest uplift reflects a market narrative that is becoming more constructive, yet still mindful of regulatory and execution risks that could limit a more aggressive rerating. Stay tuned to see how investors can track these evolving price targets and the shifting story behind them over...",
        "pubDate": "2025-12-23T05:05:56Z",
        "displayTime": "2025-12-23T05:05:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4470f143ba4f4c0e99553a639759c619",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P1sGmFSGN0yybgNh6O38Gw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4470f143ba4f4c0e99553a639759c619.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FXkL4.r20Of_qLoEXUlCrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4470f143ba4f4c0e99553a639759c619.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-st-jamess-050556451.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-st-jamess-050556451.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "STJPF"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T11:01:00+00:00",
    "headline": "BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SAN CARLOS, Calif., December 23, 2025--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST.",
    "url": "https://finance.yahoo.com/news/beone-medicines-present-44th-annual-110100546.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2ebcfc8f-e4b3-3fde-a245-ccabe6eb23b4",
      "content": {
        "id": "2ebcfc8f-e4b3-3fde-a245-ccabe6eb23b4",
        "contentType": "STORY",
        "title": "BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SAN CARLOS, Calif., December 23, 2025--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST.",
        "pubDate": "2025-12-23T11:01:00Z",
        "displayTime": "2025-12-23T11:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a7bf725260c948e5007a6e6536ab152c",
          "originalWidth": 28492,
          "originalHeight": 5743,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Na9obATFF63YaTT3.9fQYg--~B/aD01NzQzO3c9Mjg0OTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a7bf725260c948e5007a6e6536ab152c.cf.webp",
              "width": 28492,
              "height": 5743,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bqU5BUlPBOizua306Ohj8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a7bf725260c948e5007a6e6536ab152c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/beone-medicines-present-44th-annual-110100546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beone-medicines-present-44th-annual-110100546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BEIGF"
            },
            {
              "symbol": "ONC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:30:00+00:00",
    "headline": "Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "VAUGHAN, Ontario, December 23, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:",
    "url": "https://finance.yahoo.com/news/bausch-lomb-participate-44th-annual-123000341.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6cc798fd-db56-3ad8-8d32-d6c2420033b9",
      "content": {
        "id": "6cc798fd-db56-3ad8-8d32-d6c2420033b9",
        "contentType": "STORY",
        "title": "Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "VAUGHAN, Ontario, December 23, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:",
        "pubDate": "2025-12-23T12:30:00Z",
        "displayTime": "2025-12-23T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/12a1da7b15dff69db7793b52ed3a9e04",
          "originalWidth": 4152,
          "originalHeight": 327,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UtZqOqJPchXPh9ArgXy5QQ--~B/aD0zMjc7dz00MTUyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/12a1da7b15dff69db7793b52ed3a9e04.cf.webp",
              "width": 4152,
              "height": 327,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PQ71YCqUoHZUqqzjjfBb6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/12a1da7b15dff69db7793b52ed3a9e04.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bausch-lomb-participate-44th-annual-123000341.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bausch-lomb-participate-44th-annual-123000341.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BLCO"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:00:00+00:00",
    "headline": "Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
    "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "9869c13c-5ed7-3be1-9c3d-42e5c5c2f083",
      "content": {
        "id": "9869c13c-5ed7-3be1-9c3d-42e5c5c2f083",
        "contentType": "STORY",
        "title": "Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
        "pubDate": "2025-12-23T12:00:00Z",
        "displayTime": "2025-12-23T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147",
          "originalWidth": 400,
          "originalHeight": 146,
          "caption": "BT Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZyjXugroCeu5vlW6wYuCXA--~B/aD0xNDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147.cf.webp",
              "width": 400,
              "height": 146,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DPQWAvlZo522o8ucV.R5NA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/300dde1e8ea06c7a46071d80b01c0147.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-2026-j-120000548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T11:05:20+00:00",
    "headline": "How Auna’s Evolving Mexico Strategy Is Rewriting The Investment Story",
    "summary": "Auna's latest update has triggered a subtle reset in its long term fair value narrative, with the fair value estimate easing from about 10.67 to 10.42 as the discount rate edges higher from roughly 9.20% to 9.41% amid lingering concerns over regional expansion and leverage. While bulls frame this as a more achievable base that could set the stage for upside if Mexico ramps and the balance sheet improves, bears see the lower target as a reflection of tempered confidence in near term growth and...",
    "url": "https://finance.yahoo.com/news/auna-evolving-mexico-strategy-rewriting-110520745.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f7b78b30-1566-3622-a216-23c7ccfffc3f",
      "content": {
        "id": "f7b78b30-1566-3622-a216-23c7ccfffc3f",
        "contentType": "STORY",
        "title": "How Auna’s Evolving Mexico Strategy Is Rewriting The Investment Story",
        "description": "",
        "summary": "Auna's latest update has triggered a subtle reset in its long term fair value narrative, with the fair value estimate easing from about 10.67 to 10.42 as the discount rate edges higher from roughly 9.20% to 9.41% amid lingering concerns over regional expansion and leverage. While bulls frame this as a more achievable base that could set the stage for upside if Mexico ramps and the balance sheet improves, bears see the lower target as a reflection of tempered confidence in near term growth and...",
        "pubDate": "2025-12-23T11:05:20Z",
        "displayTime": "2025-12-23T11:05:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4a502612fd94fa7765656091ba791336",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6RJ7wv.8gin.BsmtuC_3PA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4a502612fd94fa7765656091ba791336.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vbHFagSfztJ8rwuj8OHCiw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4a502612fd94fa7765656091ba791336.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/auna-evolving-mexico-strategy-rewriting-110520745.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/auna-evolving-mexico-strategy-rewriting-110520745.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AUNA"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T13:05:00+00:00",
    "headline": "BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference. Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12th, 2026. A live and archived webcast will be available on the “Events & Presentations” pa",
    "url": "https://finance.yahoo.com/news/billiontoone-participate-44th-annual-j-130500317.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "85e64635-b3ef-3b8c-a690-d1212552344a",
      "content": {
        "id": "85e64635-b3ef-3b8c-a690-d1212552344a",
        "contentType": "STORY",
        "title": "BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference. Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12th, 2026. A live and archived webcast will be available on the “Events & Presentations” pa",
        "pubDate": "2025-12-23T13:05:00Z",
        "displayTime": "2025-12-23T13:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/4002b0a31048c4f4d512618615069dc4",
          "originalWidth": 809,
          "originalHeight": 425,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/siwkscFr8iz03dpboSO5GQ--~B/aD00MjU7dz04MDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4002b0a31048c4f4d512618615069dc4.cf.webp",
              "width": 809,
              "height": 425,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EwneB16hVRWWyPNzF1u0ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4002b0a31048c4f4d512618615069dc4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/billiontoone-participate-44th-annual-j-130500317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/billiontoone-participate-44th-annual-j-130500317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BLLN"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T14:00:00+00:00",
    "headline": "LivaNova to Present at J.P. Morgan Healthcare Conference in January",
    "summary": "LONDON, December 23, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30 p.m. Pacific Standard Time.",
    "url": "https://finance.yahoo.com/news/livanova-present-j-p-morgan-140000299.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b1c4b17e-eb4a-34dc-941e-2607b0ef6d35",
      "content": {
        "id": "b1c4b17e-eb4a-34dc-941e-2607b0ef6d35",
        "contentType": "STORY",
        "title": "LivaNova to Present at J.P. Morgan Healthcare Conference in January",
        "description": "",
        "summary": "LONDON, December 23, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30 p.m. Pacific Standard Time.",
        "pubDate": "2025-12-23T14:00:00Z",
        "displayTime": "2025-12-23T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/10ac647c3e1f6ad408906788324bc953",
          "originalWidth": 4954,
          "originalHeight": 1470,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZpK8OuSK79BQy6hNHaeW3g--~B/aD0xNDcwO3c9NDk1NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/10ac647c3e1f6ad408906788324bc953.cf.webp",
              "width": 4954,
              "height": 1470,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MPOTRO0xY8638ax3ZLBgSg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/10ac647c3e1f6ad408906788324bc953.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/livanova-present-j-p-morgan-140000299.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/livanova-present-j-p-morgan-140000299.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LIVN"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T14:00:00+00:00",
    "headline": "Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass. and SAN DIEGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron Renaud, President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 12, 2025, at 11:00 a.m. PT. About Kailera TherapeuticsKailera Therapeutics (Kailera) is an advanced clinical-stage biotec",
    "url": "https://finance.yahoo.com/news/kailera-therapeutics-present-44th-annual-140000607.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "b98e2f74-4de8-35f6-ad94-2d2ffc8b0db9",
      "content": {
        "id": "b98e2f74-4de8-35f6-ad94-2d2ffc8b0db9",
        "contentType": "STORY",
        "title": "Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "WALTHAM, Mass. and SAN DIEGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron Renaud, President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 12, 2025, at 11:00 a.m. PT. About Kailera TherapeuticsKailera Therapeutics (Kailera) is an advanced clinical-stage biotec",
        "pubDate": "2025-12-23T14:00:00Z",
        "displayTime": "2025-12-23T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/c855a19058756add378cafbb5bc319fc",
          "originalWidth": 3200,
          "originalHeight": 1800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xwx6BGh.5pxx1Hzqyo6JBg--~B/aD0xODAwO3c9MzIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c855a19058756add378cafbb5bc319fc.cf.webp",
              "width": 3200,
              "height": 1800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PXKEkYvPdfI.PW99eCfDoA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c855a19058756add378cafbb5bc319fc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kailera-therapeutics-present-44th-annual-140000607.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kailera-therapeutics-present-44th-annual-140000607.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T13:53:00+00:00",
    "headline": "Henlius CEO Dr. Jason Zhu to Deliver a Keynote Presentation at JPM 2026",
    "summary": "The 44th J.P. Morgan Healthcare Conference will take place from January 12 to 15, 2026, in San Francisco, USA. Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius (2696.HK), has been invited to attend and will deliver a keynote presentation on January 15 (PST).",
    "url": "https://finance.yahoo.com/news/henlius-ceo-dr-jason-zhu-135300997.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "59a1a6ad-b00c-3d70-89a9-fb2b3c8646e3",
      "content": {
        "id": "59a1a6ad-b00c-3d70-89a9-fb2b3c8646e3",
        "contentType": "STORY",
        "title": "Henlius CEO Dr. Jason Zhu to Deliver a Keynote Presentation at JPM 2026",
        "description": "",
        "summary": "The 44th J.P. Morgan Healthcare Conference will take place from January 12 to 15, 2026, in San Francisco, USA. Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius (2696.HK), has been invited to attend and will deliver a keynote presentation on January 15 (PST).",
        "pubDate": "2025-12-23T13:53:00Z",
        "displayTime": "2025-12-23T13:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/95e985aee4a65376f7efc577ca72911d",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BCuah7LkQM1vrnZhlJ.Hfw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/95e985aee4a65376f7efc577ca72911d.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6hSpZws2sHsOuP6.gS1GbQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/95e985aee4a65376f7efc577ca72911d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/henlius-ceo-dr-jason-zhu-135300997.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/henlius-ceo-dr-jason-zhu-135300997.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "2696.HK"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T13:00:03+00:00",
    "headline": "3 Great Mutual Fund Picks for Your Retirement",
    "summary": "These three top-ranked, best-performing and well-managed funds can help you maximize your retirement portfolio returns.",
    "url": "https://finance.yahoo.com/news/3-great-mutual-fund-picks-130003196.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "65479383-4853-3bcb-879a-3bbf39b95512",
      "content": {
        "id": "65479383-4853-3bcb-879a-3bbf39b95512",
        "contentType": "STORY",
        "title": "3 Great Mutual Fund Picks for Your Retirement",
        "description": "",
        "summary": "These three top-ranked, best-performing and well-managed funds can help you maximize your retirement portfolio returns.",
        "pubDate": "2025-12-23T13:00:03Z",
        "displayTime": "2025-12-23T13:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9.bMA28djqdXWkJ0xgkrvA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yGQaN1QLRXutAaqBqcTUKw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-great-mutual-fund-picks-130003196.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-great-mutual-fund-picks-130003196.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AICCX"
            },
            {
              "symbol": "AICFX"
            },
            {
              "symbol": "AIVSX"
            },
            {
              "symbol": "CICAX"
            },
            {
              "symbol": "CICCX"
            },
            {
              "symbol": "CICEX"
            },
            {
              "symbol": "CICFX"
            },
            {
              "symbol": "FAOOX"
            },
            {
              "symbol": "FCIAX"
            },
            {
              "symbol": "FFICX"
            },
            {
              "symbol": "ICAFX"
            },
            {
              "symbol": "RIBEX"
            },
            {
              "symbol": "RICAX"
            },
            {
              "symbol": "RICBX"
            },
            {
              "symbol": "RICCX"
            },
            {
              "symbol": "RICEX"
            },
            {
              "symbol": "RICFX"
            },
            {
              "symbol": "RICGX"
            },
            {
              "symbol": "RICHX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T10:30:00+00:00",
    "headline": "Wall Street Sees Cyclicals Rallying as Economic Growth Picks Up",
    "summary": "Federal Reserve rate cuts are likely with inflation cooling.  Stock pickers are looking for alternatives to artificial intelligence plays and the American consumer continues to spend.  Together it’s a near-perfect recipe for shares in companies that are most closely tied to the economic cycle.",
    "url": "https://finance.yahoo.com/news/wall-street-sees-cyclicals-rallying-103000417.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "9e92e3a1-8d3a-3221-af20-923bbdac33f3",
      "content": {
        "id": "9e92e3a1-8d3a-3221-af20-923bbdac33f3",
        "contentType": "STORY",
        "title": "Wall Street Sees Cyclicals Rallying as Economic Growth Picks Up",
        "description": "",
        "summary": "Federal Reserve rate cuts are likely with inflation cooling.  Stock pickers are looking for alternatives to artificial intelligence plays and the American consumer continues to spend.  Together it’s a near-perfect recipe for shares in companies that are most closely tied to the economic cycle.",
        "pubDate": "2025-12-23T10:30:00Z",
        "displayTime": "2025-12-23T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/b7a8a22e64c443202dad3255e2706fb7",
          "originalWidth": 1340,
          "originalHeight": 810,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sNeTVeTdX6khL6i2A.AdfQ--~B/aD04MTA7dz0xMzQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_holding_pen_162/b7a8a22e64c443202dad3255e2706fb7.cf.webp",
              "width": 1340,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/32KkY7x81Y_PL2Va0c3p4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/b7a8a22e64c443202dad3255e2706fb7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-sees-cyclicals-rallying-103000417.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-sees-cyclicals-rallying-103000417.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "DLTR"
            },
            {
              "symbol": "^DJT"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "CAT"
            },
            {
              "symbol": "GAP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]